Corrigendum to ‘Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma’ [Euro J Cancer 171 (2022) 232–241]

Published:October 27, 2022DOI:
      The authors regret that Carles Fabregat-Franco's name was incorrectly given in the original article as Carles Fabregat. This has now been corrected in the online article. The correct author details are:
      Carles Fabregat-Franco b
      b Gastrointestinal Cancer Unit, Vall d’Hebron University Hospital & Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
      The authors would like to apologize for any inconvenience caused.

      Linked Article